MOLECULES-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=575637, encodeId=871e5e5637fa, content=请问要求实验难度大吗？深吗？DZGan 2019-03-29 00:00:00 发表: 终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的, beContent=DZGan 2019-03-29 00:00:00 发表: 终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=191c2546910, createdName=12532bbcm11暂无昵称, createdTime=Sat Aug 31 00:00:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213887, encodeId=4749121388e55, content=审稿速度:1.0 偏重的研究方向：天然产物 经验分享：我投的有机化学特刊，审稿超快，3.31投的，4.15大修，给了10天时间。审稿人也很友好，提问的都是能回答的问题，然后按照意见把文章优化。4.20返修回去，4.23接收。Molecules真的太牛了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58165652757, createdName=ms6000001569791384, createdTime=Sun Apr 24 13:08:34 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584631, encodeId=f70c58463135, content=都需要Chen Doctor 2020-01-17 00:00:00 发表: 请问只需要通讯作者的机构邮箱吗？谢谢, beContent=Chen Doctor 2020-01-17 00:00:00 发表: 请问只需要通讯作者的机构邮箱吗？谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/b6cec48d5dd2fc6e5ecef552a3cb7c45/900c4584a37d3b9cc0b65b71b29c4629.jpg, createdBy=64d42033211, createdName=yekongdea, createdTime=Wed Feb 12 00:00:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221268, encodeId=ddae122126883, content=投稿命中率:75.0 偏重的研究方向：中药单体 经验分享：杂志效率太高了，5.1投稿，5.13大修，5.19修回，5.20接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Fri May 20 20:11:19 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578241, encodeId=4c395e82411c, content=请问投分子杂志的小伙伴，编辑向我要通讯作者的简历，和机构邮箱，简历怎么写啊，机构邮箱没有怎么办啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b55205809, createdName=1272985302_20746683, createdTime=Mon Oct 21 09:36:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958685, encodeId=8b7395868541, content=偏重的研究方向：药理 经验分享：前前后后从投稿到接收用了一个月左右，用来毕业的，速度还是很快的，两个多周给审稿意见，十天修回直接接收了，总体来说编辑很nice，各种问题都给解决了，很赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae155446846, createdName=ms9000001139041689, createdTime=Tue Apr 20 10:42:55 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588017, encodeId=731958801e4e, content=请问投稿之后就是pending review，状态多久才会变啊spiritak_34827477 2020-02-23 20:42:00 发表: 审稿神速 1.31投稿 2.10major revision 2.19修回 2.23接收编辑态度也很好总体难度不大就是版面费略贵, beContent=spiritak_34827477 2020-02-23 20:42:00 发表: 审稿神速 1.31投稿 2.10major revision 2.19修回 2.23接收编辑态度也很好总体难度不大就是版面费略贵, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28f35204186, createdName=Miss 懵, createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198522, encodeId=8583119852228, content=请问谁有这个期刊endnote参考文献的模板吗，分享一下呗，万分感谢！邮箱980421032@qq.com, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca806530545, createdName=ms4000002062261057, createdTime=Tue Mar 01 23:11:44 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967268, encodeId=ff2996e26866, content=请问为什么从Molecules.进去投稿，投完杂志变成Medicines了呢？这两者是什么关系呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3eac5505252, createdName=李白儿, createdTime=Thu May 20 17:02:40 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095753, encodeId=f2741095e53c8, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2019-08-31 12532bbcm11暂无昵称

请问要求实验难度大吗？深吗？DZGan 2019-03-29 00:00:00 发表:
终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的

DZGan 2019-03-29 00:00:00 发表: 终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的

133 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=575637, encodeId=871e5e5637fa, content=请问要求实验难度大吗？深吗？DZGan 2019-03-29 00:00:00 发表: 终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的, beContent=DZGan 2019-03-29 00:00:00 发表: 终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=191c2546910, createdName=12532bbcm11暂无昵称, createdTime=Sat Aug 31 00:00:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213887, encodeId=4749121388e55, content=审稿速度:1.0 偏重的研究方向：天然产物 经验分享：我投的有机化学特刊，审稿超快，3.31投的，4.15大修，给了10天时间。审稿人也很友好，提问的都是能回答的问题，然后按照意见把文章优化。4.20返修回去，4.23接收。Molecules真的太牛了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58165652757, createdName=ms6000001569791384, createdTime=Sun Apr 24 13:08:34 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584631, encodeId=f70c58463135, content=都需要Chen Doctor 2020-01-17 00:00:00 发表: 请问只需要通讯作者的机构邮箱吗？谢谢, beContent=Chen Doctor 2020-01-17 00:00:00 发表: 请问只需要通讯作者的机构邮箱吗？谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/b6cec48d5dd2fc6e5ecef552a3cb7c45/900c4584a37d3b9cc0b65b71b29c4629.jpg, createdBy=64d42033211, createdName=yekongdea, createdTime=Wed Feb 12 00:00:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221268, encodeId=ddae122126883, content=投稿命中率:75.0 偏重的研究方向：中药单体 经验分享：杂志效率太高了，5.1投稿，5.13大修，5.19修回，5.20接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Fri May 20 20:11:19 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578241, encodeId=4c395e82411c, content=请问投分子杂志的小伙伴，编辑向我要通讯作者的简历，和机构邮箱，简历怎么写啊，机构邮箱没有怎么办啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b55205809, createdName=1272985302_20746683, createdTime=Mon Oct 21 09:36:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958685, encodeId=8b7395868541, content=偏重的研究方向：药理 经验分享：前前后后从投稿到接收用了一个月左右，用来毕业的，速度还是很快的，两个多周给审稿意见，十天修回直接接收了，总体来说编辑很nice，各种问题都给解决了，很赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae155446846, createdName=ms9000001139041689, createdTime=Tue Apr 20 10:42:55 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588017, encodeId=731958801e4e, content=请问投稿之后就是pending review，状态多久才会变啊spiritak_34827477 2020-02-23 20:42:00 发表: 审稿神速 1.31投稿 2.10major revision 2.19修回 2.23接收编辑态度也很好总体难度不大就是版面费略贵, beContent=spiritak_34827477 2020-02-23 20:42:00 发表: 审稿神速 1.31投稿 2.10major revision 2.19修回 2.23接收编辑态度也很好总体难度不大就是版面费略贵, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28f35204186, createdName=Miss 懵, createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198522, encodeId=8583119852228, content=请问谁有这个期刊endnote参考文献的模板吗，分享一下呗，万分感谢！邮箱980421032@qq.com, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca806530545, createdName=ms4000002062261057, createdTime=Tue Mar 01 23:11:44 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967268, encodeId=ff2996e26866, content=请问为什么从Molecules.进去投稿，投完杂志变成Medicines了呢？这两者是什么关系呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3eac5505252, createdName=李白儿, createdTime=Thu May 20 17:02:40 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095753, encodeId=f2741095e53c8, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2022-04-24 ms6000001569791384

审稿速度:1.0
偏重的研究方向：天然产物
经验分享：我投的有机化学特刊，审稿超快，3.31投的，4.15大修，给了10天时间。审稿人也很友好，提问的都是能回答的问题，然后按照意见把文章优化。4.20返修回去，4.23接收。Molecules真的太牛了！

68 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=575637, encodeId=871e5e5637fa, content=请问要求实验难度大吗？深吗？DZGan 2019-03-29 00:00:00 发表: 终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的, beContent=DZGan 2019-03-29 00:00:00 发表: 终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=191c2546910, createdName=12532bbcm11暂无昵称, createdTime=Sat Aug 31 00:00:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213887, encodeId=4749121388e55, content=审稿速度:1.0 偏重的研究方向：天然产物 经验分享：我投的有机化学特刊，审稿超快，3.31投的，4.15大修，给了10天时间。审稿人也很友好，提问的都是能回答的问题，然后按照意见把文章优化。4.20返修回去，4.23接收。Molecules真的太牛了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58165652757, createdName=ms6000001569791384, createdTime=Sun Apr 24 13:08:34 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584631, encodeId=f70c58463135, content=都需要Chen Doctor 2020-01-17 00:00:00 发表: 请问只需要通讯作者的机构邮箱吗？谢谢, beContent=Chen Doctor 2020-01-17 00:00:00 发表: 请问只需要通讯作者的机构邮箱吗？谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/b6cec48d5dd2fc6e5ecef552a3cb7c45/900c4584a37d3b9cc0b65b71b29c4629.jpg, createdBy=64d42033211, createdName=yekongdea, createdTime=Wed Feb 12 00:00:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221268, encodeId=ddae122126883, content=投稿命中率:75.0 偏重的研究方向：中药单体 经验分享：杂志效率太高了，5.1投稿，5.13大修，5.19修回，5.20接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Fri May 20 20:11:19 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578241, encodeId=4c395e82411c, content=请问投分子杂志的小伙伴，编辑向我要通讯作者的简历，和机构邮箱，简历怎么写啊，机构邮箱没有怎么办啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b55205809, createdName=1272985302_20746683, createdTime=Mon Oct 21 09:36:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958685, encodeId=8b7395868541, content=偏重的研究方向：药理 经验分享：前前后后从投稿到接收用了一个月左右，用来毕业的，速度还是很快的，两个多周给审稿意见，十天修回直接接收了，总体来说编辑很nice，各种问题都给解决了，很赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae155446846, createdName=ms9000001139041689, createdTime=Tue Apr 20 10:42:55 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588017, encodeId=731958801e4e, content=请问投稿之后就是pending review，状态多久才会变啊spiritak_34827477 2020-02-23 20:42:00 发表: 审稿神速 1.31投稿 2.10major revision 2.19修回 2.23接收编辑态度也很好总体难度不大就是版面费略贵, beContent=spiritak_34827477 2020-02-23 20:42:00 发表: 审稿神速 1.31投稿 2.10major revision 2.19修回 2.23接收编辑态度也很好总体难度不大就是版面费略贵, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28f35204186, createdName=Miss 懵, createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198522, encodeId=8583119852228, content=请问谁有这个期刊endnote参考文献的模板吗，分享一下呗，万分感谢！邮箱980421032@qq.com, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca806530545, createdName=ms4000002062261057, createdTime=Tue Mar 01 23:11:44 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967268, encodeId=ff2996e26866, content=请问为什么从Molecules.进去投稿，投完杂志变成Medicines了呢？这两者是什么关系呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3eac5505252, createdName=李白儿, createdTime=Thu May 20 17:02:40 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095753, encodeId=f2741095e53c8, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2020-02-12 yekongdea

都需要Chen Doctor 2020-01-17 00:00:00 发表:
请问只需要通讯作者的机构邮箱吗？谢谢

Chen Doctor 2020-01-17 00:00:00 发表: 请问只需要通讯作者的机构邮箱吗？谢谢

144 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=575637, encodeId=871e5e5637fa, content=请问要求实验难度大吗？深吗？DZGan 2019-03-29 00:00:00 发表: 终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的, beContent=DZGan 2019-03-29 00:00:00 发表: 终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=191c2546910, createdName=12532bbcm11暂无昵称, createdTime=Sat Aug 31 00:00:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213887, encodeId=4749121388e55, content=审稿速度:1.0 偏重的研究方向：天然产物 经验分享：我投的有机化学特刊，审稿超快，3.31投的，4.15大修，给了10天时间。审稿人也很友好，提问的都是能回答的问题，然后按照意见把文章优化。4.20返修回去，4.23接收。Molecules真的太牛了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58165652757, createdName=ms6000001569791384, createdTime=Sun Apr 24 13:08:34 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584631, encodeId=f70c58463135, content=都需要Chen Doctor 2020-01-17 00:00:00 发表: 请问只需要通讯作者的机构邮箱吗？谢谢, beContent=Chen Doctor 2020-01-17 00:00:00 发表: 请问只需要通讯作者的机构邮箱吗？谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/b6cec48d5dd2fc6e5ecef552a3cb7c45/900c4584a37d3b9cc0b65b71b29c4629.jpg, createdBy=64d42033211, createdName=yekongdea, createdTime=Wed Feb 12 00:00:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221268, encodeId=ddae122126883, content=投稿命中率:75.0 偏重的研究方向：中药单体 经验分享：杂志效率太高了，5.1投稿，5.13大修，5.19修回，5.20接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Fri May 20 20:11:19 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578241, encodeId=4c395e82411c, content=请问投分子杂志的小伙伴，编辑向我要通讯作者的简历，和机构邮箱，简历怎么写啊，机构邮箱没有怎么办啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b55205809, createdName=1272985302_20746683, createdTime=Mon Oct 21 09:36:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958685, encodeId=8b7395868541, content=偏重的研究方向：药理 经验分享：前前后后从投稿到接收用了一个月左右，用来毕业的，速度还是很快的，两个多周给审稿意见，十天修回直接接收了，总体来说编辑很nice，各种问题都给解决了，很赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae155446846, createdName=ms9000001139041689, createdTime=Tue Apr 20 10:42:55 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588017, encodeId=731958801e4e, content=请问投稿之后就是pending review，状态多久才会变啊spiritak_34827477 2020-02-23 20:42:00 发表: 审稿神速 1.31投稿 2.10major revision 2.19修回 2.23接收编辑态度也很好总体难度不大就是版面费略贵, beContent=spiritak_34827477 2020-02-23 20:42:00 发表: 审稿神速 1.31投稿 2.10major revision 2.19修回 2.23接收编辑态度也很好总体难度不大就是版面费略贵, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28f35204186, createdName=Miss 懵, createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198522, encodeId=8583119852228, content=请问谁有这个期刊endnote参考文献的模板吗，分享一下呗，万分感谢！邮箱980421032@qq.com, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca806530545, createdName=ms4000002062261057, createdTime=Tue Mar 01 23:11:44 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967268, encodeId=ff2996e26866, content=请问为什么从Molecules.进去投稿，投完杂志变成Medicines了呢？这两者是什么关系呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3eac5505252, createdName=李白儿, createdTime=Thu May 20 17:02:40 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095753, encodeId=f2741095e53c8, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2022-05-20 ms5000001536683150

投稿命中率:75.0
偏重的研究方向：中药单体
经验分享：杂志效率太高了，5.1投稿，5.13大修，5.19修回，5.20接收

77 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=575637, encodeId=871e5e5637fa, content=请问要求实验难度大吗？深吗？DZGan 2019-03-29 00:00:00 发表: 终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的, beContent=DZGan 2019-03-29 00:00:00 发表: 终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=191c2546910, createdName=12532bbcm11暂无昵称, createdTime=Sat Aug 31 00:00:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213887, encodeId=4749121388e55, content=审稿速度:1.0 偏重的研究方向：天然产物 经验分享：我投的有机化学特刊，审稿超快，3.31投的，4.15大修，给了10天时间。审稿人也很友好，提问的都是能回答的问题，然后按照意见把文章优化。4.20返修回去，4.23接收。Molecules真的太牛了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58165652757, createdName=ms6000001569791384, createdTime=Sun Apr 24 13:08:34 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584631, encodeId=f70c58463135, content=都需要Chen Doctor 2020-01-17 00:00:00 发表: 请问只需要通讯作者的机构邮箱吗？谢谢, beContent=Chen Doctor 2020-01-17 00:00:00 发表: 请问只需要通讯作者的机构邮箱吗？谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/b6cec48d5dd2fc6e5ecef552a3cb7c45/900c4584a37d3b9cc0b65b71b29c4629.jpg, createdBy=64d42033211, createdName=yekongdea, createdTime=Wed Feb 12 00:00:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221268, encodeId=ddae122126883, content=投稿命中率:75.0 偏重的研究方向：中药单体 经验分享：杂志效率太高了，5.1投稿，5.13大修，5.19修回，5.20接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Fri May 20 20:11:19 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578241, encodeId=4c395e82411c, content=请问投分子杂志的小伙伴，编辑向我要通讯作者的简历，和机构邮箱，简历怎么写啊，机构邮箱没有怎么办啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b55205809, createdName=1272985302_20746683, createdTime=Mon Oct 21 09:36:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958685, encodeId=8b7395868541, content=偏重的研究方向：药理 经验分享：前前后后从投稿到接收用了一个月左右，用来毕业的，速度还是很快的，两个多周给审稿意见，十天修回直接接收了，总体来说编辑很nice，各种问题都给解决了，很赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae155446846, createdName=ms9000001139041689, createdTime=Tue Apr 20 10:42:55 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588017, encodeId=731958801e4e, content=请问投稿之后就是pending review，状态多久才会变啊spiritak_34827477 2020-02-23 20:42:00 发表: 审稿神速 1.31投稿 2.10major revision 2.19修回 2.23接收编辑态度也很好总体难度不大就是版面费略贵, beContent=spiritak_34827477 2020-02-23 20:42:00 发表: 审稿神速 1.31投稿 2.10major revision 2.19修回 2.23接收编辑态度也很好总体难度不大就是版面费略贵, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28f35204186, createdName=Miss 懵, createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198522, encodeId=8583119852228, content=请问谁有这个期刊endnote参考文献的模板吗，分享一下呗，万分感谢！邮箱980421032@qq.com, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca806530545, createdName=ms4000002062261057, createdTime=Tue Mar 01 23:11:44 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967268, encodeId=ff2996e26866, content=请问为什么从Molecules.进去投稿，投完杂志变成Medicines了呢？这两者是什么关系呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3eac5505252, createdName=李白儿, createdTime=Thu May 20 17:02:40 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095753, encodeId=f2741095e53c8, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2019-10-21 1272985302_20746683

请问投分子杂志的小伙伴，编辑向我要通讯作者的简历，和机构邮箱，简历怎么写啊，机构邮箱没有怎么办啊

150 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=575637, encodeId=871e5e5637fa, content=请问要求实验难度大吗？深吗？DZGan 2019-03-29 00:00:00 发表: 终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的, beContent=DZGan 2019-03-29 00:00:00 发表: 终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=191c2546910, createdName=12532bbcm11暂无昵称, createdTime=Sat Aug 31 00:00:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213887, encodeId=4749121388e55, content=审稿速度:1.0 偏重的研究方向：天然产物 经验分享：我投的有机化学特刊，审稿超快，3.31投的，4.15大修，给了10天时间。审稿人也很友好，提问的都是能回答的问题，然后按照意见把文章优化。4.20返修回去，4.23接收。Molecules真的太牛了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58165652757, createdName=ms6000001569791384, createdTime=Sun Apr 24 13:08:34 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584631, encodeId=f70c58463135, content=都需要Chen Doctor 2020-01-17 00:00:00 发表: 请问只需要通讯作者的机构邮箱吗？谢谢, beContent=Chen Doctor 2020-01-17 00:00:00 发表: 请问只需要通讯作者的机构邮箱吗？谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/b6cec48d5dd2fc6e5ecef552a3cb7c45/900c4584a37d3b9cc0b65b71b29c4629.jpg, createdBy=64d42033211, createdName=yekongdea, createdTime=Wed Feb 12 00:00:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221268, encodeId=ddae122126883, content=投稿命中率:75.0 偏重的研究方向：中药单体 经验分享：杂志效率太高了，5.1投稿，5.13大修，5.19修回，5.20接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Fri May 20 20:11:19 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578241, encodeId=4c395e82411c, content=请问投分子杂志的小伙伴，编辑向我要通讯作者的简历，和机构邮箱，简历怎么写啊，机构邮箱没有怎么办啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b55205809, createdName=1272985302_20746683, createdTime=Mon Oct 21 09:36:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958685, encodeId=8b7395868541, content=偏重的研究方向：药理 经验分享：前前后后从投稿到接收用了一个月左右，用来毕业的，速度还是很快的，两个多周给审稿意见，十天修回直接接收了，总体来说编辑很nice，各种问题都给解决了，很赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae155446846, createdName=ms9000001139041689, createdTime=Tue Apr 20 10:42:55 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588017, encodeId=731958801e4e, content=请问投稿之后就是pending review，状态多久才会变啊spiritak_34827477 2020-02-23 20:42:00 发表: 审稿神速 1.31投稿 2.10major revision 2.19修回 2.23接收编辑态度也很好总体难度不大就是版面费略贵, beContent=spiritak_34827477 2020-02-23 20:42:00 发表: 审稿神速 1.31投稿 2.10major revision 2.19修回 2.23接收编辑态度也很好总体难度不大就是版面费略贵, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28f35204186, createdName=Miss 懵, createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198522, encodeId=8583119852228, content=请问谁有这个期刊endnote参考文献的模板吗，分享一下呗，万分感谢！邮箱980421032@qq.com, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca806530545, createdName=ms4000002062261057, createdTime=Tue Mar 01 23:11:44 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967268, encodeId=ff2996e26866, content=请问为什么从Molecules.进去投稿，投完杂志变成Medicines了呢？这两者是什么关系呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3eac5505252, createdName=李白儿, createdTime=Thu May 20 17:02:40 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095753, encodeId=f2741095e53c8, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2021-04-20 ms9000001139041689

偏重的研究方向：药理
经验分享：前前后后从投稿到接收用了一个月左右，用来毕业的，速度还是很快的，两个多周给审稿意见，十天修回直接接收了，总体来说编辑很nice，各种问题都给解决了，很赞

98 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=575637, encodeId=871e5e5637fa, content=请问要求实验难度大吗？深吗？DZGan 2019-03-29 00:00:00 发表: 终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的, beContent=DZGan 2019-03-29 00:00:00 发表: 终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=191c2546910, createdName=12532bbcm11暂无昵称, createdTime=Sat Aug 31 00:00:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213887, encodeId=4749121388e55, content=审稿速度:1.0 偏重的研究方向：天然产物 经验分享：我投的有机化学特刊，审稿超快，3.31投的，4.15大修，给了10天时间。审稿人也很友好，提问的都是能回答的问题，然后按照意见把文章优化。4.20返修回去，4.23接收。Molecules真的太牛了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58165652757, createdName=ms6000001569791384, createdTime=Sun Apr 24 13:08:34 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584631, encodeId=f70c58463135, content=都需要Chen Doctor 2020-01-17 00:00:00 发表: 请问只需要通讯作者的机构邮箱吗？谢谢, beContent=Chen Doctor 2020-01-17 00:00:00 发表: 请问只需要通讯作者的机构邮箱吗？谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/b6cec48d5dd2fc6e5ecef552a3cb7c45/900c4584a37d3b9cc0b65b71b29c4629.jpg, createdBy=64d42033211, createdName=yekongdea, createdTime=Wed Feb 12 00:00:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221268, encodeId=ddae122126883, content=投稿命中率:75.0 偏重的研究方向：中药单体 经验分享：杂志效率太高了，5.1投稿，5.13大修，5.19修回，5.20接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Fri May 20 20:11:19 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578241, encodeId=4c395e82411c, content=请问投分子杂志的小伙伴，编辑向我要通讯作者的简历，和机构邮箱，简历怎么写啊，机构邮箱没有怎么办啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b55205809, createdName=1272985302_20746683, createdTime=Mon Oct 21 09:36:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958685, encodeId=8b7395868541, content=偏重的研究方向：药理 经验分享：前前后后从投稿到接收用了一个月左右，用来毕业的，速度还是很快的，两个多周给审稿意见，十天修回直接接收了，总体来说编辑很nice，各种问题都给解决了，很赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae155446846, createdName=ms9000001139041689, createdTime=Tue Apr 20 10:42:55 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588017, encodeId=731958801e4e, content=请问投稿之后就是pending review，状态多久才会变啊spiritak_34827477 2020-02-23 20:42:00 发表: 审稿神速 1.31投稿 2.10major revision 2.19修回 2.23接收编辑态度也很好总体难度不大就是版面费略贵, beContent=spiritak_34827477 2020-02-23 20:42:00 发表: 审稿神速 1.31投稿 2.10major revision 2.19修回 2.23接收编辑态度也很好总体难度不大就是版面费略贵, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28f35204186, createdName=Miss 懵, createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198522, encodeId=8583119852228, content=请问谁有这个期刊endnote参考文献的模板吗，分享一下呗，万分感谢！邮箱980421032@qq.com, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca806530545, createdName=ms4000002062261057, createdTime=Tue Mar 01 23:11:44 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967268, encodeId=ff2996e26866, content=请问为什么从Molecules.进去投稿，投完杂志变成Medicines了呢？这两者是什么关系呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3eac5505252, createdName=李白儿, createdTime=Thu May 20 17:02:40 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095753, encodeId=f2741095e53c8, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2020-04-02 Miss 懵

请问投稿之后就是pending review，状态多久才会变啊spiritak_34827477 2020-02-23 20:42:00 发表:
审稿神速 1.31投稿 2.10major revision 2.19修回 2.23接收编辑态度也很好总体难度不大就是版面费略贵

spiritak_34827477 2020-02-23 20:42:00 发表: 审稿神速 1.31投稿 2.10major revision 2.19修回 2.23接收编辑态度也很好总体难度不大就是版面费略贵

138 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=575637, encodeId=871e5e5637fa, content=请问要求实验难度大吗？深吗？DZGan 2019-03-29 00:00:00 发表: 终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的, beContent=DZGan 2019-03-29 00:00:00 发表: 终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=191c2546910, createdName=12532bbcm11暂无昵称, createdTime=Sat Aug 31 00:00:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213887, encodeId=4749121388e55, content=审稿速度:1.0 偏重的研究方向：天然产物 经验分享：我投的有机化学特刊，审稿超快，3.31投的，4.15大修，给了10天时间。审稿人也很友好，提问的都是能回答的问题，然后按照意见把文章优化。4.20返修回去，4.23接收。Molecules真的太牛了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58165652757, createdName=ms6000001569791384, createdTime=Sun Apr 24 13:08:34 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584631, encodeId=f70c58463135, content=都需要Chen Doctor 2020-01-17 00:00:00 发表: 请问只需要通讯作者的机构邮箱吗？谢谢, beContent=Chen Doctor 2020-01-17 00:00:00 发表: 请问只需要通讯作者的机构邮箱吗？谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/b6cec48d5dd2fc6e5ecef552a3cb7c45/900c4584a37d3b9cc0b65b71b29c4629.jpg, createdBy=64d42033211, createdName=yekongdea, createdTime=Wed Feb 12 00:00:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221268, encodeId=ddae122126883, content=投稿命中率:75.0 偏重的研究方向：中药单体 经验分享：杂志效率太高了，5.1投稿，5.13大修，5.19修回，5.20接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Fri May 20 20:11:19 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578241, encodeId=4c395e82411c, content=请问投分子杂志的小伙伴，编辑向我要通讯作者的简历，和机构邮箱，简历怎么写啊，机构邮箱没有怎么办啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b55205809, createdName=1272985302_20746683, createdTime=Mon Oct 21 09:36:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958685, encodeId=8b7395868541, content=偏重的研究方向：药理 经验分享：前前后后从投稿到接收用了一个月左右，用来毕业的，速度还是很快的，两个多周给审稿意见，十天修回直接接收了，总体来说编辑很nice，各种问题都给解决了，很赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae155446846, createdName=ms9000001139041689, createdTime=Tue Apr 20 10:42:55 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588017, encodeId=731958801e4e, content=请问投稿之后就是pending review，状态多久才会变啊spiritak_34827477 2020-02-23 20:42:00 发表: 审稿神速 1.31投稿 2.10major revision 2.19修回 2.23接收编辑态度也很好总体难度不大就是版面费略贵, beContent=spiritak_34827477 2020-02-23 20:42:00 发表: 审稿神速 1.31投稿 2.10major revision 2.19修回 2.23接收编辑态度也很好总体难度不大就是版面费略贵, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28f35204186, createdName=Miss 懵, createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198522, encodeId=8583119852228, content=请问谁有这个期刊endnote参考文献的模板吗，分享一下呗，万分感谢！邮箱980421032@qq.com, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca806530545, createdName=ms4000002062261057, createdTime=Tue Mar 01 23:11:44 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967268, encodeId=ff2996e26866, content=请问为什么从Molecules.进去投稿，投完杂志变成Medicines了呢？这两者是什么关系呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3eac5505252, createdName=李白儿, createdTime=Thu May 20 17:02:40 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095753, encodeId=f2741095e53c8, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2022-03-01 ms4000002062261057

请问谁有这个期刊endnote参考文献的模板吗，分享一下呗，万分感谢！邮箱980421032@qq.com

0 0

[GetPortalCommentsPageByObjectIdResponse(id=575637, encodeId=871e5e5637fa, content=请问要求实验难度大吗？深吗？DZGan 2019-03-29 00:00:00 发表: 终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的, beContent=DZGan 2019-03-29 00:00:00 发表: 终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=191c2546910, createdName=12532bbcm11暂无昵称, createdTime=Sat Aug 31 00:00:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213887, encodeId=4749121388e55, content=审稿速度:1.0 偏重的研究方向：天然产物 经验分享：我投的有机化学特刊，审稿超快，3.31投的，4.15大修，给了10天时间。审稿人也很友好，提问的都是能回答的问题，然后按照意见把文章优化。4.20返修回去，4.23接收。Molecules真的太牛了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58165652757, createdName=ms6000001569791384, createdTime=Sun Apr 24 13:08:34 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584631, encodeId=f70c58463135, content=都需要Chen Doctor 2020-01-17 00:00:00 发表: 请问只需要通讯作者的机构邮箱吗？谢谢, beContent=Chen Doctor 2020-01-17 00:00:00 发表: 请问只需要通讯作者的机构邮箱吗？谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/b6cec48d5dd2fc6e5ecef552a3cb7c45/900c4584a37d3b9cc0b65b71b29c4629.jpg, createdBy=64d42033211, createdName=yekongdea, createdTime=Wed Feb 12 00:00:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221268, encodeId=ddae122126883, content=投稿命中率:75.0 偏重的研究方向：中药单体 经验分享：杂志效率太高了，5.1投稿，5.13大修，5.19修回，5.20接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Fri May 20 20:11:19 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578241, encodeId=4c395e82411c, content=请问投分子杂志的小伙伴，编辑向我要通讯作者的简历，和机构邮箱，简历怎么写啊，机构邮箱没有怎么办啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b55205809, createdName=1272985302_20746683, createdTime=Mon Oct 21 09:36:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958685, encodeId=8b7395868541, content=偏重的研究方向：药理 经验分享：前前后后从投稿到接收用了一个月左右，用来毕业的，速度还是很快的，两个多周给审稿意见，十天修回直接接收了，总体来说编辑很nice，各种问题都给解决了，很赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae155446846, createdName=ms9000001139041689, createdTime=Tue Apr 20 10:42:55 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588017, encodeId=731958801e4e, content=请问投稿之后就是pending review，状态多久才会变啊spiritak_34827477 2020-02-23 20:42:00 发表: 审稿神速 1.31投稿 2.10major revision 2.19修回 2.23接收编辑态度也很好总体难度不大就是版面费略贵, beContent=spiritak_34827477 2020-02-23 20:42:00 发表: 审稿神速 1.31投稿 2.10major revision 2.19修回 2.23接收编辑态度也很好总体难度不大就是版面费略贵, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28f35204186, createdName=Miss 懵, createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198522, encodeId=8583119852228, content=请问谁有这个期刊endnote参考文献的模板吗，分享一下呗，万分感谢！邮箱980421032@qq.com, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca806530545, createdName=ms4000002062261057, createdTime=Tue Mar 01 23:11:44 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967268, encodeId=ff2996e26866, content=请问为什么从Molecules.进去投稿，投完杂志变成Medicines了呢？这两者是什么关系呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3eac5505252, createdName=李白儿, createdTime=Thu May 20 17:02:40 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095753, encodeId=f2741095e53c8, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2021-05-20 李白儿

请问为什么从Molecules.进去投稿，投完杂志变成Medicines了呢？这两者是什么关系呢

108 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=575637, encodeId=871e5e5637fa, content=请问要求实验难度大吗？深吗？DZGan 2019-03-29 00:00:00 发表: 终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的, beContent=DZGan 2019-03-29 00:00:00 发表: 终于到自己写经验了。我投的是姜黄素的special issue，所以速度比较快些。这是我接触过从投稿到接受最快的杂志，三月二号投稿，三月28接收，中间大修一次小修一次。不是大家说的水刊，审稿人非常严谨，大到文章主题，小到试剂盒的货号都指出来要我补充，从审稿人的意见中学到很多。从投稿系统，格式模板，编辑都服务态度上，每一点都感觉很舒服，可能因为MDPI效率高，加上是OA，所以大家会觉得水，其实大可不必担心，要想中还是有一点难度的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=191c2546910, createdName=12532bbcm11暂无昵称, createdTime=Sat Aug 31 00:00:00 CST 2019, time=2019-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213887, encodeId=4749121388e55, content=审稿速度:1.0 偏重的研究方向：天然产物 经验分享：我投的有机化学特刊，审稿超快，3.31投的，4.15大修，给了10天时间。审稿人也很友好，提问的都是能回答的问题，然后按照意见把文章优化。4.20返修回去，4.23接收。Molecules真的太牛了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58165652757, createdName=ms6000001569791384, createdTime=Sun Apr 24 13:08:34 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584631, encodeId=f70c58463135, content=都需要Chen Doctor 2020-01-17 00:00:00 发表: 请问只需要通讯作者的机构邮箱吗？谢谢, beContent=Chen Doctor 2020-01-17 00:00:00 发表: 请问只需要通讯作者的机构邮箱吗？谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/b6cec48d5dd2fc6e5ecef552a3cb7c45/900c4584a37d3b9cc0b65b71b29c4629.jpg, createdBy=64d42033211, createdName=yekongdea, createdTime=Wed Feb 12 00:00:00 CST 2020, time=2020-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221268, encodeId=ddae122126883, content=投稿命中率:75.0 偏重的研究方向：中药单体 经验分享：杂志效率太高了，5.1投稿，5.13大修，5.19修回，5.20接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Fri May 20 20:11:19 CST 2022, time=2022-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578241, encodeId=4c395e82411c, content=请问投分子杂志的小伙伴，编辑向我要通讯作者的简历，和机构邮箱，简历怎么写啊，机构邮箱没有怎么办啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=15b55205809, createdName=1272985302_20746683, createdTime=Mon Oct 21 09:36:00 CST 2019, time=2019-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958685, encodeId=8b7395868541, content=偏重的研究方向：药理 经验分享：前前后后从投稿到接收用了一个月左右，用来毕业的，速度还是很快的，两个多周给审稿意见，十天修回直接接收了，总体来说编辑很nice，各种问题都给解决了，很赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae155446846, createdName=ms9000001139041689, createdTime=Tue Apr 20 10:42:55 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588017, encodeId=731958801e4e, content=请问投稿之后就是pending review，状态多久才会变啊spiritak_34827477 2020-02-23 20:42:00 发表: 审稿神速 1.31投稿 2.10major revision 2.19修回 2.23接收编辑态度也很好总体难度不大就是版面费略贵, beContent=spiritak_34827477 2020-02-23 20:42:00 发表: 审稿神速 1.31投稿 2.10major revision 2.19修回 2.23接收编辑态度也很好总体难度不大就是版面费略贵, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28f35204186, createdName=Miss 懵, createdTime=Thu Apr 02 00:00:00 CST 2020, time=2020-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198522, encodeId=8583119852228, content=请问谁有这个期刊endnote参考文献的模板吗，分享一下呗，万分感谢！邮箱980421032@qq.com, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca806530545, createdName=ms4000002062261057, createdTime=Tue Mar 01 23:11:44 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967268, encodeId=ff2996e26866, content=请问为什么从Molecules.进去投稿，投完杂志变成Medicines了呢？这两者是什么关系呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3eac5505252, createdName=李白儿, createdTime=Thu May 20 17:02:40 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095753, encodeId=f2741095e53c8, content=什么是协同作用？什么是相加作用？两者有什么区别？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2021-12-28 ms6000000264964247

什么是协同作用？什么是相加作用？两者有什么区别？

73 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务